SCHEMBL12936634

SCHEMBL12936634

Nc1ccc(CCN2CC(=O)N(CCC(c3ccccc3)c3ccccc3)C(CC(=O)NCCc3ccc(Cl)cc3Cl)C2=O)c(Cl)c1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APAF1 O14727 6/20 0.66
CASP3 P42574 6/20 0.66
CASP9 P55211 6/20 0.66
CYCS P99999 6/20 0.66
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HPGD P15428 1/20 0.42
METAP2 P50579 4/20 0.39
LMNA P02545 1/20 0.38
CCR5 P51681 1/20 0.38
ACHE P22303 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
P2RX7 Q99572 2/20 0.36
METAP1 P53582 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5955953 0.95 APAF1 (0.69) APAF1CASP3CASP9CYCSKDM4E
SCHEMBL9885477 0.91 APAF1 (0.64) APAF1CASP3CASP9CYCSKDM4E
SCHEMBL3701083 0.85 APAF1 (0.75) APAF1CASP3CASP9CYCSKDM4E
SCHEMBL5956385 0.83 APAF1 (0.52) APAF1CASP3CASP9CYCSKDM4E
SCHEMBL3703369 0.81 APAF1 (0.65) APAF1CASP3CASP9CYCSCCR5
SCHEMBL16743047 0.81 APAF1 (0.52) APAF1CASP3CASP9CYCSKDM4E
SCHEMBL9885474 0.80 APAF1 (0.68) APAF1CASP3CASP9CYCSCCR5
SCHEMBL3704146 0.79 APAF1 (1.00) APAF1CASP3CASP9CYCSMETAP2
SCHEMBL5956659 0.79 APAF1 (0.48) APAF1CASP3CASP9CYCSKDM4E
SCHEMBL3698229 0.79 APAF1 (0.50) APAF1CASP3CASP9CYCSKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011012746-A2 APAF-1 INHIBITOR COMPOUNDS LABORATORIOS SALVAT, S.A. (ES) 2011-02-03 WO disclosed